Dr. Othman is the Martha Ann and Harold M. Selzman, M.D. Endowed Chair

Dr. Naga Chalasani currently serves as David W. Crabb Professor of Medicine and Vice President for Academic Affairs at Indiana University School of Medicine and Indiana University Health. He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020) and Chair of the Department of Medicine (2020-2021, interim) at Indiana University School of Medicine.

I am a pediatric gastroenterologist with expertise in pediatric nutrition and obesity at Cincinnati Children's Hospital Medical Center. I am a Professor at the University of Cincinnati, the Program Director of our Advanced Nutrition Fellowship and the Associate Program Director of our Steatohepatitis Center. My clinical research is focused on MASLD.

Dr. Victor Chen is an Associate Professor of Medicine at Johns Hopkins University School of Medicine, serving both the Division of Gastroenterology and Hepatology and the Division of Addiction Medicine. As a clinician-investigator supported by the National Institutes of Health and specializing in transplant hepatology and addiction medicine, Dr. Chen researches and cares for patients with general or transplant-related liver conditions.

I am currently Professor and Vice Chair for Research of the Department of Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth). I received my PhD in drug metabolism and toxicology from the University of Toronto, Canada in 1999, followed by postdoctoral training at the National Heart Lung and Blood Institute (NHLBI). I joined the School of Pharmacy, University of Colorado as an Assistant Professor in 2002, and was promote to Associate and Full Professor in 2009 and 2015, respectively.

Dr. Daniel Leung is a clinician-scientist in pediatric gastroenterology and hepatology who has devoted his career to the study and care of children with cystic fibrosis associated liver disease (CFLD) and CF gastrointestinal and nutritional complications. He is well recognized for his work in the validation of serum and imaging biomarkers of pediatric liver fibrosis as predictors of clinical outcomes in CF. Dr.

Affiliation Tokyo Women's Medical University (TWMU),
Department, Institute of Gastroenterology, Department of Internal Medicine
Current Position, Lecturer

Areas of interest Metabolic dysfunction-associated steatotic liver disease(MASLD)/ metabolic dysfunction-associated steatohepatitis(MASH)
Liver cirrhosis
Fontan-associated liver disease (FALD)
【Educational and Career Experiences】
Aug 2009- present TWMU
Aug 2006-Aug 2009 Dept. of Cellular & Molecular Medicine in University of California, San Diego, Howard Hughes Medical Institute (HHMI)

Kenichi IKEJIMA is currently a Professor of Department of Gastroenterology at Juntendo University Graduate School of Medicine since 2017. His expertise covers both clinical and basic aspects of a variety of liver diseases, especially focusing on steatotic liver disease.

Dr. Girgrah is the Chief Wellness Officer at Ochsner Health. He leads the efforts of the Office of Professional Well-Being (OPW) at Ochsner Health which is charged with improving the professional fulfillment of their employed physicians and healthcare workforce focusing on enhanced practice efficiency and personal and team resilience and building an organizational culture that promotes provider well-being. Dr. Girgrah received both his medical degree and Ph.D. from the University of Toronto.